Bharat Immunologicals Financial Statements Trends

This module enables investors to look at Bharat Immunologicals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as , but also many exotic indicators such as . This module is a perfect complement to use when analyzing Bharat Immunologicals Valuation or Volatility. It can also complement various Bharat Immunologicals Technical models. Check also Trending Equities.

Profit Margin Analysis

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Bharat Immunologicals 
Profit Margin 
 = 
Net Income 
Revenue 
X
100 
 = 
(4.18) %

About Profit Margin

In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd has Profit Margin of -4.18%. This is much lower than that of the sector, and significantly lower than that of Profit Margin industry, The Profit Margin for all stocks is over 1000% higher than the company.

Bharat Immunologicals Fundamental Drivers Relationships

Bharat Immunologicals Biologicals Corp Ltd is number one stock in profit margin category among related companies. It is number one stock in number of employees category among related companies .

Did you try this?

Run Companies Directory Now
   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Hide  View All  Next  Launch Companies Directory
Return On Asset(1.69) %
Profit Margin(4.18) %
Operating Margin(5.13) %
Current Valuation862.5 M
Shares Outstanding43.18 M
Price to Earning(28.02) times
Price to Book2.50 times
Price to Sales0.66 times
Revenue1.28 B
Gross Profit119 M
EBITDA(56.51 M)
Net Income(53.46 M)
Cash and Equivalents152.27 M
Cash per Share3.55 times
Total Debt177.56 M
Debt to Equity0.50 times
Current Ratio1.69 times
Earnings Per Share(1.24) times
Market Capitalization1.5 B
Z Score4.8